ISPC — iSpecimen Income Statement
0.000.00%
Last trade - 00:00- $5.46m
- -$1.42m
- $1.93m
Annual income statement for iSpecimen, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 11.1 | 10.4 | 9.93 | 9.29 | 1.93 |
| Cost of Revenue | |||||
| Gross Profit | 5.89 | 5.65 | 5.11 | 3.99 | 0.024 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 19.3 | 20.6 | 21.1 | 22 | 10.9 |
| Operating Profit | -8.14 | -10.2 | -11.2 | -12.7 | -8.98 |
| Total Net Non Operating Interest Income / Expense | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -8.96 | -10.2 | -11.1 | -12.5 | -10.5 |
| Net Income After Taxes | -8.96 | -10.2 | -11.1 | -12.5 | -10.5 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -8.96 | -10.2 | -11.1 | -12.5 | -10.5 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -8.96 | -10.2 | -11.1 | -12.5 | -10.5 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -618 | -893 | -982 | -685 | -74.9 |